Indonesia
· Delayed Price · Currency is IDR IDX:MEDS Statistics
Total Valuation
IDX:MEDS has a market cap or net worth of IDR 78.13 billion. The enterprise value is 83.09 billion.
| Market Cap | 78.13B |
| Enterprise Value | 83.09B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:MEDS has 1.56 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 1.56B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 76.24% |
| Owned by Institutions (%) | n/a |
| Float | 371.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.22 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 39.98 |
| P/OCF Ratio | 35.03 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.74 |
| EV / Sales | 13.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 42.52 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.88 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.66 |
| Interest Coverage | -17.98 |
Financial Efficiency
Return on equity (ROE) is -14.02% and return on invested capital (ROIC) is -8.03%.
| Return on Equity (ROE) | -14.02% |
| Return on Assets (ROA) | -7.61% |
| Return on Invested Capital (ROIC) | -8.03% |
| Return on Capital Employed (ROCE) | -14.56% |
| Revenue Per Employee | 355.06M |
| Profits Per Employee | -474.09M |
| Employee Count | 18 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.96 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 50.00 |
| 200-Day Moving Average | 51.98 |
| Relative Strength Index (RSI) | 40.16 |
| Average Volume (20 Days) | 5,945 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:MEDS had revenue of IDR 6.39 billion and -8.53 billion in losses. Loss per share was -5.46.
| Revenue | 6.39B |
| Gross Profit | 525.30M |
| Operating Income | -8.67B |
| Pretax Income | -8.27B |
| Net Income | -8.53B |
| EBITDA | -4.47B |
| EBIT | -8.67B |
| Loss Per Share | -5.46 |
Balance Sheet
The company has 232.09 million in cash and 5.19 billion in debt, giving a net cash position of -4.96 billion or -3.18 per share.
| Cash & Cash Equivalents | 232.09M |
| Total Debt | 5.19B |
| Net Cash | -4.96B |
| Net Cash Per Share | -3.18 |
| Equity (Book Value) | 56.62B |
| Book Value Per Share | 36.23 |
| Working Capital | 10.73B |
Cash Flow
In the last 12 months, operating cash flow was 2.23 billion and capital expenditures -275.84 million, giving a free cash flow of 1.95 billion.
| Operating Cash Flow | 2.23B |
| Capital Expenditures | -275.84M |
| Free Cash Flow | 1.95B |
| FCF Per Share | 1.25 |
Margins
Gross margin is 8.22%, with operating and profit margins of -135.72% and -133.52%.
| Gross Margin | 8.22% |
| Operating Margin | -135.72% |
| Pretax Margin | -129.46% |
| Profit Margin | -133.52% |
| EBITDA Margin | -69.97% |
| EBIT Margin | -135.72% |
| FCF Margin | 30.58% |
Dividends & Yields
IDX:MEDS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.92% |
| FCF Yield | 2.50% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:MEDS has an Altman Z-Score of 5.18.
| Altman Z-Score | 5.18 |
| Piotroski F-Score | n/a |